Analysts think AVXL stock price could increase by 399%
Feb 14, 2025, 12:25 PM
11.16%
What does AVXL do
Anavex Life Sciences, a New York-based biopharmaceutical company, develops therapeutics for neurodegenerative diseases and employs 40 staff. Its lead compound, ANAVEX 2-73, targets Alzheimer's and Parkinson's diseases.
6 analysts think AVXL stock price will increase by 399.10%. The current median analyst target is $42.27 compared to a current stock price of $8.47. The lowest analysts target is $15.15 and the highest analyst target is $48.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.